In the 12 months ending 31 October 2016, what was:
1. The number of patients who had a blood culture positive for Klebsiella pneumoniae (Group A)
2. In Group A, the number of patients who had a blood culture positive for Klebsiella pneumoniae, with the organism found to be resistant to meropenem, resistant to ertapenem, OR reported positive for a carbapenemase (Group “CRKPb”).
3. In Group A, the number of patients who had a blood culture positive for Klebsiella pneumoniae, with the organism NEITHER found to be resistant to meropenem, NOR resistant to ertapenem, NOR reported positive for a carbapenemase (Group “CSKPb”).
4. Within Group CRKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae found to be resistant to meropenem, resistant to ertapenem, OR reported positive for a carbapenemase, and 6 days after the specimen date.
5. Within Group CRKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae found to be resistant to meropenem, resistant to ertapenem, OR reported positive for a carbapenemase, and 30 days after the specimen date.
6. Within Group CSKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae NEITHER found to be resistant to meropenem, NOR resistant to ertapenem, NOR reported positive for a carbapenemase, and 6 days after the specimen date.
7. Within Group CSKPb, the percentage of patients who had died in the period between the specimen date of the first blood culture that became positive for Klebsiella pneumoniae NEITHER found to be resistant to meropenem, NOR resistant to ertapenem, NOR reported positive for a carbapenemase, and 30 days after the specimen date.”
Please provide answers on the same questions for the 12 months period ending 31 October 2015.
